These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Diagnosis and treatment of cancer of unknown origin]. Vázquez Rivera F; Barón Duarte FJ; López López R An Med Interna; 2000 Nov; 17(11):603-8. PubMed ID: 11322036 [TBL] [Abstract][Full Text] [Related]
6. Understanding and managing cancer of unknown primary. Symons J Br J Nurs; 2008 Oct 9-22; 17(18):1160-4. PubMed ID: 18946393 [TBL] [Abstract][Full Text] [Related]
7. Cancer of unknown primary: does the key lie in molecular diagnostics? Green AC Cytopathology; 2015 Feb; 26(1):61-3. PubMed ID: 25683360 [No Abstract] [Full Text] [Related]
8. [Diagnostic and therapeutic approach in cancer of metastatic presentation and unknown origin]. Losa Gaspà F; Germà Lluch JR; Camacho Cuartero L; Niubó Daniel R; Albareda Boleda JM; Sanuy Jiménez B; Martos Rodríguez A Rev Clin Esp; 2002 Nov; 202(11):604-14. PubMed ID: 12392650 [No Abstract] [Full Text] [Related]
9. Worst case scenario: carcinoma of unknown origin. Cibull ML Diagn Cytopathol; 2006 May; 34(5):311-2. PubMed ID: 16604548 [No Abstract] [Full Text] [Related]
10. Cancer of the unknown primary site. Diggs CH Wis Med J; 1988 Oct; 87(10):18-20. PubMed ID: 3232395 [No Abstract] [Full Text] [Related]
11. Cancers of unknown primary site: ESMO clinical recommendation for diagnosis, treatment and follow-up. Briasoulis E; Pavlidis N; Felip E; Ann Oncol; 2008 May; 19 Suppl 2():ii106-7. PubMed ID: 18456742 [No Abstract] [Full Text] [Related]
12. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Fizazi K; Greco FA; Pavlidis N; Pentheroudakis G; Ann Oncol; 2011 Sep; 22 Suppl 6():vi64-8. PubMed ID: 21908507 [No Abstract] [Full Text] [Related]
13. The outcome is known, the primary not. Mulder NH Neth J Med; 1988 Apr; 32(3-4):157-8. PubMed ID: 3362268 [No Abstract] [Full Text] [Related]
14. Tumour markers in cancers of unknown primary: a clinical perspective. Savage P Ann Clin Biochem; 2006 Jan; 43(Pt 1):1-2. PubMed ID: 16390602 [No Abstract] [Full Text] [Related]
15. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP). Briasoulis E; Tolis C; Bergh J; Pavlidis N; Ann Oncol; 2005; 16 Suppl 1():i75-6. PubMed ID: 15888766 [No Abstract] [Full Text] [Related]
16. New look at the old management of unknown primary. Dowden S; Miller W J Surg Oncol; 2008 Aug; 98(2):71-2. PubMed ID: 18609550 [No Abstract] [Full Text] [Related]
18. [Cancer of unknown primary site-current status and future direction]. Ichikawa Y; Okamoto I; Nakagawa K Gan To Kagaku Ryoho; 2009 Jun; 36(6):907-9. PubMed ID: 19542709 [TBL] [Abstract][Full Text] [Related]
19. Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup. Waltonen JD; Ozer E; Hall NC; Schuller DE; Agrawal A Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1024-9. PubMed ID: 19841343 [TBL] [Abstract][Full Text] [Related]
20. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Fizazi K; Greco FA; Pavlidis N; Daugaard G; Oien K; Pentheroudakis G; Ann Oncol; 2015 Sep; 26 Suppl 5():v133-8. PubMed ID: 26314775 [No Abstract] [Full Text] [Related] [Next] [New Search]